Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melanie Schwerdtfeger

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Vaccines|February 15, 2018
Virus-Like-Vaccines against HIVAnne-Marie C Andersson, Melanie Schwerdtfeger, Peter J Holst
Journal of Translational Medicine|May 26, 2019
Virus-like vaccines against HIV/SIV synergize with a subdominant antigen T cell vaccineMelanie Schwerdtfeger, Anne-Marie Carola Andersson, Lasse Neukirch, et al.
Translational Oncology|May 29, 2021
Long non-coding RNAs in cancer stem cellsMelanie Schwerdtfeger, Vincenzo Desiderio, Sebastian Kobold, et al.
Current Hematologic Malignancy Reports|May 3, 2021
Chimeric Antigen Receptor-Modified T Cells and T Cell-Engaging Bispecific Antibodies: Different Tools for the Same JobMelanie Schwerdtfeger, Mohamed-Reda Benmebarek, Stefan Endres, et al.
Journal of Pharmaceutical Sciences|May 18, 2026
Lyophilization of a viral vaccine: Strategies for surrogate use in analytical characterization of cake properties and considerations on virus infectivityAndrea Arsiccio, Felix Reuter, Sabine Ulamec, et al.
Cancer Treatment Reviews|June 8, 2020
The role of autophagy in resistance to targeted therapiesLuigi Mele, Vitale Del Vecchio, Davide Liccardo, et al.
Cell Death & Disease|October 14, 2020
β<sub>2</sub>-AR blockade potentiates MEK1/2 inhibitor effect on HNSCC by regulating the Nrf2-mediated defense mechanismLuigi Mele, Vitale Del Vecchio, Francesco Marampon, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 12, 2022
MiR-423-5p prevents MALAT1-mediated proliferation and metastasis in prostate cancerCarmela Ferri, Anna Di Biase, Marco Bocchetti, et al.
Leukemia|January 8, 2021
A modular and controllable T cell therapy platform for acute myeloid leukemiaMohamed-Reda Benmebarek, Bruno L Cadilha, Monika Herrmann, et al.
Journal for Immunotherapy of Cancer|May 19, 2023
Bispecific antibodies redirect synthetic agonistic receptor modified T cells against melanomaFlorian Märkl, Mohamed-Reda Benmebarek, Julius Keyl, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Vaccines|February 15, 2018
Virus-Like-Vaccines against HIVAnne-Marie C Andersson, Melanie Schwerdtfeger, Peter J Holst
Journal of Translational Medicine|May 26, 2019
Virus-like vaccines against HIV/SIV synergize with a subdominant antigen T cell vaccineMelanie Schwerdtfeger, Anne-Marie Carola Andersson, Lasse Neukirch, et al.
Translational Oncology|May 29, 2021
Long non-coding RNAs in cancer stem cellsMelanie Schwerdtfeger, Vincenzo Desiderio, Sebastian Kobold, et al.
Current Hematologic Malignancy Reports|May 3, 2021
Chimeric Antigen Receptor-Modified T Cells and T Cell-Engaging Bispecific Antibodies: Different Tools for the Same JobMelanie Schwerdtfeger, Mohamed-Reda Benmebarek, Stefan Endres, et al.
Journal of Pharmaceutical Sciences|May 18, 2026
Lyophilization of a viral vaccine: Strategies for surrogate use in analytical characterization of cake properties and considerations on virus infectivityAndrea Arsiccio, Felix Reuter, Sabine Ulamec, et al.
Cancer Treatment Reviews|June 8, 2020
The role of autophagy in resistance to targeted therapiesLuigi Mele, Vitale Del Vecchio, Davide Liccardo, et al.
Cell Death & Disease|October 14, 2020
β<sub>2</sub>-AR blockade potentiates MEK1/2 inhibitor effect on HNSCC by regulating the Nrf2-mediated defense mechanismLuigi Mele, Vitale Del Vecchio, Francesco Marampon, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 12, 2022
MiR-423-5p prevents MALAT1-mediated proliferation and metastasis in prostate cancerCarmela Ferri, Anna Di Biase, Marco Bocchetti, et al.
Leukemia|January 8, 2021
A modular and controllable T cell therapy platform for acute myeloid leukemiaMohamed-Reda Benmebarek, Bruno L Cadilha, Monika Herrmann, et al.
Journal for Immunotherapy of Cancer|May 19, 2023
Bispecific antibodies redirect synthetic agonistic receptor modified T cells against melanomaFlorian Märkl, Mohamed-Reda Benmebarek, Julius Keyl, et al.
Pageof 2